Holen Sie sich die Stockscreener-App
23.58
0.65%
-0.155
Schlusskurs vom Vortag:
$23.73
Offen:
$23.42
24-Stunden-Volumen:
2.50M
Relative Volume:
2.19
Marktkapitalisierung:
$1.60B
Einnahmen:
$2.74B
Nettoeinkommen (Verlust:
$-441.40M
KGV:
-3.6055
EPS:
-6.54
Netto-Cashflow:
$13.00M
1W Leistung:
-18.97%
1M Leistung:
-29.19%
6M Leistung:
-12.92%
1J Leistung:
-43.39%
1-Tages-Spanne:
$22.73
$24.74
1-Wochen-Bereich:
$21.65
$30.50
52-Wochen-Spanne:
$19.50
$42.50
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
23.58 | 1.61B | 2.74B | -441.40M | 13.00M | -6.54 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
Top QuidelOrtho Insiders Make Bold Move With Fresh Share Purchases - TipRanks
A Look At QuidelOrtho (QDEL) Valuation After Earnings Update And CFO Transition News - Sahm
QuidelOrtho Announces Planned Retirement of Chief Financial Officer - TipRanks
Insider Buying: QuidelOrtho (NASDAQ:QDEL) Director Acquires 10,000 Shares of Stock - MarketBeat
QuidelOrtho CFO Busky buys $79k in shares By Investing.com - Investing.com Australia
Joseph Busky Purchases 3,370 Shares of QuidelOrtho (NASDAQ:QDEL) Stock - MarketBeat
QuidelOrtho CFO Busky buys $79k in shares - Investing.com
QuidelOrtho CEO Blaser buys shares worth $248,660 By Investing.com - Investing.com India
QuidelOrtho CEO Blaser buys shares worth $248,660 - Investing.com
Will QuidelOrtho Corporation benefit from rising consumer demand2025 Major Catalysts & High Accuracy Investment Signals - mfd.ru
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho Q4 results beat on both lines, but issues weak 2026 EPS guidance - MSN
QDEL Q4 Deep Dive: Margin Expansion, R&D Pipeline, and Guidance Disappoints - Finviz
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownHere's Why - MarketBeat
QDEL Stock Slumps On Mixed Wall Street Price Target Revisions After Q4 Report - Stocktwits
UBS Adjusts QuidelOrtho Price Target to $30 From $35, Maintains Neutral Rating - marketscreener.com
QuidelOrtho (NASDAQ:QDEL) Issues FY 2026 Earnings Guidance - MarketBeat
QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down - Yahoo Finance
QuidelOrtho revenue hits USD 724M in Q4 2025 - Medical Buyer
QuidelOrtho Q4 2025 slides: Revenue beats expectations despite 27% EPS drop - Investing.com Canada
QuidelOrtho Corp (QDEL) Q4 2025 Earnings Call Highlights: Strong Labs Growth Amidst Respiratory Revenue Decline - GuruFocus
QuidelOrtho Q4 2025 slides: Revenue beats expectations despite 27% EPS drop By Investing.com - Investing.com South Africa
QuidelOrtho (QDEL) Aims for Improved Margins and Strong Cash Flo - GuruFocus
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript - AOL.com
QuidelOrtho Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: QuidelOrtho Q4 2025 misses EPS, stock dips By Investing.com - Investing.com Nigeria
Earnings call transcript: QuidelOrtho Q4 2025 misses EPS, stock dips - Investing.com
QuidelOrtho Corp (NASDAQ:QDEL) Beats Q4 Earnings Estimates Despite After-Hours Stock Decline - ChartMill
QDEL Projects Significant Revenue Growth by FY26 - GuruFocus
QuidelOrtho (QDEL) Sees Mixed Growth Across Business Segments - GuruFocus
QuidelOrtho (QDEL) Exceeds Q4 Revenue Expectations with Diversif - GuruFocus
QuidelOrtho (QDEL) Projects Steady Covid-19 Revenue Through FY25 - GuruFocus
QuidelOrtho (QDEL) Projects Strong Financial Performance for FY2 - GuruFocus
QuidelOrtho (QDEL) CFO Announces Retirement Plans - GuruFocus
QuidelOrtho (QDEL) Projects FY26 Tax Rate at 24% - GuruFocus
QuidelOrtho Q4 2025 Earnings: Revenue & Profit Beat, 2026 Outlook CautiousNews and Statistics - IndexBox
QuidelOrtho Q4 Earnings Fall, Revenue Rises; Issues Guidance - marketscreener.com
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations - Finviz
QuidelOrtho: Q4 Earnings Snapshot - kare11.com
QuidelOrtho: Fourth Quarter Financial Highlights - Bitget
QuidelOrtho (NASDAQ:QDEL) Issues Earnings Results - MarketBeat
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q4 Adjusted EPS $0.46 per Share, vs. FactSet Est of $0.42 - marketscreener.com
QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results - PR Newswire
Is QuidelOrtho Corporation stock overvalued by current metricsOil Prices & Growth Focused Investment Plans - mfd.ru
QuidelOrtho (NASDAQ:QDEL) Surpasses Projections for Q4 CY2025 - Bitget
Weekly Recap: Is QuidelOrtho Corporation a turnaround storyJuly 2025 Snapshot & Weekly High Momentum Picks - baoquankhu1.vn
Why is QuidelOrtho Corporation stock going downJuly 2025 Selloffs & Weekly Chart Analysis and Guides - mfd.ru
Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow - Yahoo Finance
Earnings Preview: QuidelOrtho (QDEL) Q4 Earnings Expected to Decline - Eastern Progress
Earnings preview: QuidelOrtho (QDEL) Q4 earnings expected to decline - MSN
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Quidelortho Corporation-Aktie (QDEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):